IA plus MF markedly enhanced the median per cent reduction of ABO-specific IgM determined by flow cytometry ( primary end point ; 59 versus 23 % , P < 0.001 ) and haemagglutination ( 2 versus 1 titre steps , P < 0.001 ) , respectively .